What do drugmakers think about RFK Jr.? Why has it been so hard to bring gene therapies to market? And what tacos did Adam have this week while attending the American Society of Hematology conference?
We discuss all that and more on this week's episode of "The Readout LOUD," STAT's biotech podcast. Washington correspondent John Wilkerson joins us to discuss why drugmakers have not lobbied against Robert F. Kennedy Jr.'s nomination to lead the Department of Health and Human Services, despite his repeated criticisms of the pharmaceutical industry.
We also bring on our colleague Jason Mast to talk about the major hurdles in the field of gene therapy and how one father is trying to overcome them.
Listen Now
Subscribe to the podcast on Apple Podcasts or Spotify to never miss an episode
Visit the archive to see past episodes
No comments